Phase One Research at Rutgers Health
CLINICAL VALIDATION
Phase I successfully validated the foundational XFORCE tourniquet platform through testing at Rutgers Health. The study demonstrated significantly faster application than the current standard of care while establishing the feasibility of integrating future communication and GPS-based emergency response capabilities. These results provided the technical foundation necessary to advance into Phase II development of the TeleTQ smart tourniquet system.
Phase II Study Objectives
Critical testing and validation milestones for the tele-medical enhancement of the XFORCE platform.
Estimated Completion Date: June 2026
01
Real-Time Pressure Validation
Ensuring constant, accurate tension monitoring for immediate life-saving occlusion.
02
Physiological Monitoring
Tracking vital patient signals to provide surgeons with precise health status data.
03
GPS & Geolocation Tracking
Mapping exact casualty locations to streamline rapid evacuation and field logistics.
04
Communication & Transmission
Securing high-speed data flow between field operators and remote command centers.
05
Dead-Zone / No-GPS Operation
Testing fail-safe connectivity protocols for mission-critical reliability in isolated areas.
06
Dashboard Validation
Optimizing the Command & Control UI for intuitive, rapid decision-making under stress.
07
Mass Casualty Detection
Implementing triage AI and multi-patient tracking for large-scale emergency events.